In vivo transdermal generation of CD33 CAR T-cells towards acute myeloid leukemia |
University of California, Los Angeles / Ruby Sims, PhD |
Young Investigator Grants |
2024 |
California |
Targeting the immunosuppressive effects of Myc-hyperactivation in high-risk osteosarcoma |
Emory University / Jason Yustein, MD/PhD |
Innovation Grants |
2024 |
Georgia |
Defining how unique properties of the pediatric immune system contribute to poor efficacy of checkpoint blockade in children |
Stanford University / Adrienne Long, MD/PhD |
Young Investigator Grants |
2024 |
California |
Unraveling GABAergic interneuron-like lineage in H3G34-mutant hemispheric high-grade gliomas: their impact on network formation and invasion |
Dana-Farber Cancer Institute / Gustavo Alencastro Veiga Cruzeiro, PhD |
Young Investigator Grants |
2024 |
Massachusetts |
Capitalizing on functional genomics with targeted protein degradation in neuroblastoma |
St. Jude Children’s Research Hospital / Ian Delahunty, PhD |
Young Investigator Grants |
2024 |
Tennessee |
Gene-mediated cytotoxic immunotherapy in pediatric patients with recurrent malignant brain tumors |
University of Michigan / Andrea Franson, MD |
'A' Award Grants |
2024 |
Michigan |
Vaccine-boosted CAR T cell therapy for high risk neuroblastoma |
Children’s Hospital of Philadelphia / Timothy Spear, MD/PhD |
Young Investigator Grants |
2024 |
Pennsylvania |
Targeting Novel Inflammatory Signaling Pathways in Juvenile Myelomonocytic Leukemia |
Indiana University / Santhosh Kumar Pasupuleti, PhD |
'A' Award Grants |
2024 |
Indiana |
Systematic screening of receptor pairs combinations for improving solid tumor cancer immunotherapy |
Texas Children’s Cancer Center / Xavier Rios, MD/PhD |
'A' Award Grants |
2024 |
Texas |
Improving homing and activity of CAR T cells in pediatric sarcomas |
University of Colorado Denver / Joselyn Cruz Cruz, PhD |
Young Investigator Grants |
2024 |
Colorado |